688016 logo

Shanghai MicroPort Endovascular MedTech Co., Ltd. Stock Price

SHSE:688016 Community·CN¥12.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

688016 Share Price Performance

CN¥102.32
16.29 (18.94%)
CN¥102.32
16.29 (18.94%)
Price CN¥102.32

688016 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

1 Risk
4 Rewards

Shanghai MicroPort Endovascular MedTech Co., Ltd. Key Details

CN¥1.4b

Revenue

CN¥399.8m

Cost of Revenue

CN¥950.8m

Gross Profit

CN¥387.5m

Other Expenses

CN¥563.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 12, 2026
4.66
70.40%
41.71%
0%
View Full Analysis

About 688016

Founded
2012
Employees
822
CEO
Qing Zhu
WebsiteView website
www.endovastec.com

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft system; Cratos and Castor, a branched aortic stent graft system; Talos, a thoracic stent graft system; and Hercules, a thoracic stent graft system with low profile delivery system. It also provides Minos, an abdominal aortic stent graft and delivery System; Aorfix, an endovascular device designed for treating abdominal aortic aneurysms; Altura, a device designed for the endovascular repair of abdominal aortic aneurysms; Aegis, a bifurcated aortic stent graft system; and L-REBOA, an aortic occlusion balloon catheter. In addition, the company offers Reewarm PTX, a drug coated balloon PTA catheter; ReeAmber, a PTA balloon dilatation catheter; Reewarm, a PTA balloon dilatation catheter; Ryflumen, a peripheral high-pressure balloon dilatation catheter; and CROWNUS, a peripheral stent system; HawkMaster, a detachable fibered embolization coils; HawkNest, a fibered embolization coils; Veryan BM3D, which is designed for the treatment of symptomatic de novo lesions in the native superficial femoral artery; Vflower, a venous stent system; SeaDragon, a PTA balloon dilatation catheter; Vewatch, a vena cava filter; Vepack, a snare retrieval kit; VeinPro, an endovenous radiofrequency closure system; Reflow-speX, a support catheter; and DEMANTOID, a peripheral vascular guide wire. Further, it provides Tipspear, a transjugular liver access set. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People’s Republic of China.

Recent 688016 News & Updates

Recent updates

No updates